Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Novartis Ag (NVS)
Nine Major Drugmakers Agree To Lower Drug Prices Through TrumpRx Initiative
12/19/2025 8:45:40 PM
Novartis Breaks Ground In North Carolina For New Manufacturing Hub, To Create 700 New Jobs
12/12/2025 7:24:12 AM
Novartis Breaks Ground On US Manufacturing Hub In North Carolina; To Create 700 Jobs By 2030
12/12/2025 7:08:38 AM
Novartis Wins FDA Nod For Gene Replacement Therapy Itvisma To Treat Spinal Muscular Atrophy
11/25/2025 7:44:34 AM
Novartis To Present Data From Over 70 Abstracts, Including Hematology And Oncology At ASH And SABCS
11/25/2025 1:55:23 AM
Novartis Wins FDA Approval For Gene-Replacement Therapy Itvisma For Spinal Muscular Atrophy
11/25/2025 1:03:09 AM
Novartis Issues Updated Mid-term Sales Guidance; Upgrades Peak Sales Guidance For Kisqali, Scemblix
11/20/2025 8:29:05 AM
Novartis Sees Sales CAGR Of 5-6% Cc For 2025-2030 Period
11/20/2025 7:39:11 AM
Novartis To Build Flagship Manufacturing Hub In North Carolina
11/19/2025 10:56:58 PM
Novartis Q3 Results Climb, Despite Generic Erosion In US; Confirms FY25 Outlook
10/28/2025 2:27:08 AM
Novartis Q3 EPS $2.04; Core EPS $2.25
10/28/2025 2:03:18 AM
Novartis Deal Lifts Avidity, Domino Effect Boosts Dyne And PepGen
10/27/2025 11:19:10 AM
Novartis To Acquire Avidity Biosciences In $12 Bln Deal
10/26/2025 9:55:48 PM
Novartis' Cosentyx Meets All Endpoints In Phase III Polymyalgia Rheumatica Study
10/22/2025 2:02:16 AM
Novartis' Cosentyx Meets Endpoints In Phase III REPLENISH Trial In Polymyalgia Rheumatica
10/22/2025 1:31:54 AM
CIBC To Shift CDR Listings From Cboe Canada To TSX
10/10/2025 8:05:49 AM
FDA Approves Novartis' Rhapsido As First BTKi Oral Therapy For Chronic Spontaneous Urticaria
9/30/2025 10:52:48 PM
Amneal Pharma Submits BLA To FDA For A Proposed Biosimilar To XOLAIR
9/26/2025 8:14:40 AM
Older Articles